89ZR-BEVACIZUMAB Uses, Dosage, Side Effects and more
89ZR-BEVACIZUMAB is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).
| Attribute | Details |
|---|---|
| Trade Name | 89ZR-BEVACIZUMAB |
| Generic | Bevacizumab zirconium Zr-89 |
| Bevacizumab zirconium Zr-89 Other Names | 89ZR-BEVACIZUMAB |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
